ONCOIMMUNITY AS
BIOTECHGATE BY VENTURE VALUATION
Latest up-date: 23 Oct 2017
GENERAL INFORMATION
 
Ullernchausséen 64
Oslo Cancer Cluster, Innovation Park
0379 Oslo
Norway
Contact person Dr. Richard Stratford, Chief Executive Officer & Co-founder
Company main phone +47 (90) 015242
Website www.oncoimmunity.com
Founded (year) 2014
Source of foundation Independent foundation
   
Corporate description / mission
OncoImmunity AS is a bioinformatics company which is engaged in developing software solutions to analyse exome or RNASeq data from a sequenced tumor, and identify immunogenicity within the context of the patient’s specific HLA genotype and the patient’s specific mutated neo-antigen profile. The solution will guide the design of patient selection for clinical trials in cancer immunotherapy, and in addition support the targeted discovery of novel cancer immunotherapies.
State of ownership Private / independent
Headquarters Yes
CATEGORIZATION  
Main sector Biotechnology / R&D Services
Subsector(s)
  • Analytical services
  • Bioinformatics
Primary therapeutic area(s)
  • Neoplasms / cancer / oncology
 
Business model
  • Service company
Customer segments
  • Large biotech & big pharma
  • Small biotech
FINANCING DETAILS
Money raised to date
(at least)
USD 15.00M
Financing details
n/a